These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33171706)

  • 1. An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.
    Moolman C; Sluis RV; Beteck RM; Legoabe LJ
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.
    Jirage D; Keenan SM; Waters NC
    Infect Disord Drug Targets; 2010 Jun; 10(3):134-46. PubMed ID: 20334624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments.
    Mustière R; Vanelle P; Primas N
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33334080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New medicines to improve control and contribute to the eradication of malaria.
    Wells TN; Alonso PL; Gutteridge WE
    Nat Rev Drug Discov; 2009 Nov; 8(11):879-91. PubMed ID: 19834482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.
    Zhang VM; Chavchich M; Waters NC
    Curr Top Med Chem; 2012; 12(5):456-72. PubMed ID: 22242850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone-3-diarylethers: a new class of antimalarial drug.
    Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
    Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW; Diagana TT; Yeung BK
    Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodial Kinase Inhibitors: License to Cure?
    Cabrera DG; Horatscheck A; Wilson CR; Basarab G; Eyermann CJ; Chibale K
    J Med Chem; 2018 Sep; 61(18):8061-8077. PubMed ID: 29771541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Currently Available Antimalarials.
    Gorobets NY; Sedash YV; Singh BK; Poonam ; Rathi B
    Curr Top Med Chem; 2017; 17(19):2143-2157. PubMed ID: 28137228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multiple-stage antimalarial agent that inhibits protein synthesis.
    Baragaña B; Hallyburton I; Lee MC; Norcross NR; Grimaldi R; Otto TD; Proto WR; Blagborough AM; Meister S; Wirjanata G; Ruecker A; Upton LM; Abraham TS; Almeida MJ; Pradhan A; Porzelle A; Luksch T; Martínez MS; Luksch T; Bolscher JM; Woodland A; Norval S; Zuccotto F; Thomas J; Simeons F; Stojanovski L; Osuna-Cabello M; Brock PM; Churcher TS; Sala KA; Zakutansky SE; Jiménez-Díaz MB; Sanz LM; Riley J; Basak R; Campbell M; Avery VM; Sauerwein RW; Dechering KJ; Noviyanti R; Campo B; Frearson JA; Angulo-Barturen I; Ferrer-Bazaga S; Gamo FJ; Wyatt PG; Leroy D; Siegl P; Delves MJ; Kyle DE; Wittlin S; Marfurt J; Price RN; Sinden RE; Winzeler EA; Charman SA; Bebrevska L; Gray DW; Campbell S; Fairlamb AH; Willis PA; Rayner JC; Fidock DA; Read KD; Gilbert IH
    Nature; 2015 Jun; 522(7556):315-20. PubMed ID: 26085270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission.
    Baker DA; Stewart LB; Large JM; Bowyer PW; Ansell KH; Jiménez-Díaz MB; El Bakkouri M; Birchall K; Dechering KJ; Bouloc NS; Coombs PJ; Whalley D; Harding DJ; Smiljanic-Hurley E; Wheldon MC; Walker EM; Dessens JT; Lafuente MJ; Sanz LM; Gamo FJ; Ferrer SB; Hui R; Bousema T; Angulo-Barturén I; Merritt AT; Croft SL; Gutteridge WE; Kettleborough CA; Osborne SA
    Nat Commun; 2017 Sep; 8(1):430. PubMed ID: 28874661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Plasmodium PI(4)K to eliminate malaria.
    McNamara CW; Lee MC; Lim CS; Lim SH; Roland J; Simon O; Yeung BK; Chatterjee AK; McCormack SL; Manary MJ; Zeeman AM; Dechering KJ; Kumar TS; Henrich PP; Gagaring K; Ibanez M; Kato N; Kuhen KL; Fischli C; Nagle A; Rottmann M; Plouffe DM; Bursulaya B; Meister S; Rameh L; Trappe J; Haasen D; Timmerman M; Sauerwein RW; Suwanarusk R; Russell B; Renia L; Nosten F; Tully DC; Kocken CH; Glynne RJ; Bodenreider C; Fidock DA; Diagana TT; Winzeler EA
    Nature; 2013 Dec; 504(7479):248-253. PubMed ID: 24284631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.